These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18753424)

  • 21. Evaluation of antioxidant status of female diabetic patients in Nnamdi Azikiwe University Teaching Hospital, Anambra State, Nigeria.
    Okuonghae EO; Onyenekwe CC; Ahaneku JE; Ukibe NR; Nwani PO; Asomugha AL; Osakue NO; Aidomeh F; Awalu CC
    Br J Biomed Sci; 2015; 72(4):164-7. PubMed ID: 26738397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between self-monitoring of blood glucose and glycaemic control among patients attending an urban diabetes clinic in Nigeria.
    Iwuala SO; Olamoyegun MA; Sabir AA; Fasanmade OA
    Ann Afr Med; 2015; 14(4):182-7. PubMed ID: 26470743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study.
    Carrington MJ; Cohen N; Wiley JF
    Diabetes Res Clin Pract; 2017 May; 127():89-96. PubMed ID: 28324867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycaemic control in hospitalised diabetic patients at the University Hospital Basel in 2002 and in 2005.
    Thomann R; Lenherr C; Keller U
    Swiss Med Wkly; 2009 Sep; 139(37-38):547-52. PubMed ID: 19838872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
    Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
    Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
    Zenari L; Marangoni A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic Control and Associated Self-Management Behaviours in Diabetic Outpatients: A Hospital Based Observation Study in Lusaka, Zambia.
    Musenge EM; Michelo C; Mudenda B; Manankov A
    J Diabetes Res; 2016; 2016():7934654. PubMed ID: 26798654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
    Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
    Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus.
    Song KH; Ahn YB; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK
    Diabet Med; 1999 Dec; 16(12):1036-9. PubMed ID: 10656233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.
    Kautzky-Willer A; Kosi L; Lin J; Mihaljevic R
    Diabetes Obes Metab; 2015 Jun; 17(6):533-540. PubMed ID: 25678212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control.
    Trivedi H; Gray LJ; Seidu S; Davies MJ; Charpentier G; Lindblad U; Kellner C; Nolan J; Pazderska A; Rutten G; Trento M; Khunti K
    Prim Care Diabetes; 2017 Oct; 11(5):414-420. PubMed ID: 28684227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.
    Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM
    Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.